Protea Fund - Sectoral Emerging Markets Healthcare Fund PF USD/  LU1033753986  /

The Sub-Fund offers an investment opportunity that focuses on these growth drivers. Investments are focused on companies offering emerging therapies and services across all healthcare segments and addressing significant unmet medical need. This Sub-Fund invests in healthcare companies domiciled in the emerging markets, across all market caps. Emerging markets are undergoing rapid population aging, leading to higher incidence of age-related disease and rising utilization of therapies and healthcare services. Alongside demographic shifts, rising discretionary income, a growing focus on innovation, favorable regulatory and drug approval trends, as well as increased government spending on healthcare are supporting strong growth for healthcare companies across emerging geographies. The Sub-Fund may, invest in transferable securities and money market instruments from new issues to benefit from particularly innovative projects in the healthcare sector. Emerging markets in connection with the Sub-Fund are all countries considered as such by the World Bank, the International Finance Corporation or the United Nations or that are included in the MSCI Emerging Markets Index or the MSCI Frontier Markets (FM) Index. The Sub-Fund may invest up to 66% of its net assets via Shanghai-Hong Kong Stock Connect and Shenzhen-Hong Kong Stock Connect in China A-Shares. Up to 10% of the Sub Fund's net assets may be invested in Special Purpose Acquisitions Companies. Up to 33% of the Sub-Fund's net assets may be invested outside the aforementioned investment universe including in equities of issuers of other business segments than healthcare and fixed and variable interest securities.

The Sub-Fund offers an investment opportunity that focuses on these growth drivers. Investments are focused on companies offering emerging therapies and services across all healthcare segments and addressing significant unmet medical need.